secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001295947-24-000023
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer Q1 revenue $267.1M beats expectations; reaffirms FY2025 outlook
--------------------------------------------------------------------------------

- Q1 GAAP EPS $0.98, adjusted EPS $0.90; revenue down 4.4% YoY but ahead of internal plan.
- Cash from operations $54.8M (+13.9% YoY); reduced debt $35M and repurchased $26M in shares.
- North American OTC revenue $232.3M (-5.6%); International OTC $34.8M (+5.0% driven by Hydralyte).
- FY2025 guidance reaffirmed: revenue $1.125-$1.140B, adjusted EPS $4.40-$4.46, FCF $240M+.
- CEO cited earlier supply of Clear Eyes products as primary driver of Q1 beat over expectations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594724000023/0001295947-24-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594724000023/pbh-20240808.htm
  HTML page:      https://secwatch.observer/filing/0001295947-24-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer